214 related articles for article (PubMed ID: 20659219)
21. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
22. Emerging strategies for the management of hepatocellular carcinoma.
Kudo M
Dig Dis; 2014; 32(6):655-7. PubMed ID: 25376280
[No Abstract] [Full Text] [Related]
23. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
Nagoshi S; Fujiwara K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
[No Abstract] [Full Text] [Related]
24. Hepatocellular carcinoma.
Marrero JA
Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival.
Lee SH; Choi HC; Jeong SH; Lee KH; Chung JI; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Choi HC; Yoon CJ; Kang SG
J Am Geriatr Soc; 2011 Feb; 59(2):241-50. PubMed ID: 21275934
[TBL] [Abstract][Full Text] [Related]
26. [Changed diagnosis and treatment of hepatocellular carcinoma].
van Nieuwkerk CM; Rauws EA; Tytgat GN; Reeders JW; Jones AE; Gouma DJ
Ned Tijdschr Geneeskd; 1996 Apr; 140(17):922-6. PubMed ID: 8676971
[No Abstract] [Full Text] [Related]
27. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma.
Zaydfudim V; Whiteside MA; Griffin MR; Feurer ID; Wright JK; Pinson CW
Ann Surg Oncol; 2010 Dec; 17(12):3104-11. PubMed ID: 20585872
[TBL] [Abstract][Full Text] [Related]
28. Management of the hepatocellular carcinoma.
Hefaiedh R; Elloumi H; Ouakaa A; Elloumi H; Kochlef A; Gargouri D; Kilani A; Romani M; Kharrat J; Ghorbel A
Tunis Med; 2009 Nov; 87(11):721-5. PubMed ID: 20209827
[TBL] [Abstract][Full Text] [Related]
29. The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma.
Kotoh K; Sakai H; Morotomi I; Nawata H
Hepatogastroenterology; 1995 Jul; 42(3):197-200. PubMed ID: 7590564
[TBL] [Abstract][Full Text] [Related]
30. [Quality of life in the treatment of hepatocellular carcinoma].
Shiina S; Teratani T; Omata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():797-800. PubMed ID: 11762059
[No Abstract] [Full Text] [Related]
31. Treatment of hepatocellular carcinoma.
Blum HE
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
[TBL] [Abstract][Full Text] [Related]
32. Multimodal treatment of stage IVa hepatocellular carcinoma.
Harada T; Matsuo K; Inoue T; Inoue T; Tamesue S; Inoue T
Hepatogastroenterology; 1996; 43(11):1154-8. PubMed ID: 8908544
[TBL] [Abstract][Full Text] [Related]
33. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
[TBL] [Abstract][Full Text] [Related]
34. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
[TBL] [Abstract][Full Text] [Related]
36. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
[TBL] [Abstract][Full Text] [Related]
37. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma.
Lau WY; Leow CK; Li AK
Br J Hosp Med; 1997 Feb 5-18; 57(3):101-4. PubMed ID: 9196588
[TBL] [Abstract][Full Text] [Related]
39. [Current therapeutic strategies in hepatocellular carcinoma, Part 1].
Wallner I; Hartmann H; Ramadori G
Leber Magen Darm; 1994 Jul; 24(4):150, 153-4. PubMed ID: 7934608
[TBL] [Abstract][Full Text] [Related]
40. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
Kotoh K; Sakai H; Sakamoto S; Nakayama S; Satoh M; Morotomi I; Nawata H
Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
